<code id='EB073AC84B'></code><style id='EB073AC84B'></style>
    • <acronym id='EB073AC84B'></acronym>
      <center id='EB073AC84B'><center id='EB073AC84B'><tfoot id='EB073AC84B'></tfoot></center><abbr id='EB073AC84B'><dir id='EB073AC84B'><tfoot id='EB073AC84B'></tfoot><noframes id='EB073AC84B'>

    • <optgroup id='EB073AC84B'><strike id='EB073AC84B'><sup id='EB073AC84B'></sup></strike><code id='EB073AC84B'></code></optgroup>
        1. <b id='EB073AC84B'><label id='EB073AC84B'><select id='EB073AC84B'><dt id='EB073AC84B'><span id='EB073AC84B'></span></dt></select></label></b><u id='EB073AC84B'></u>
          <i id='EB073AC84B'><strike id='EB073AC84B'><tt id='EB073AC84B'><pre id='EB073AC84B'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:9614
          Good CEOs 2022
          Hyacinth Empinado/STAT

          It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

          This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

          advertisement

          What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Amylyx's ALS drug launch starts strong. It could be trouble for FDA
          Amylyx's ALS drug launch starts strong. It could be trouble for FDA

          MollyFerguson/STATBehindthestellarcommerciallaunchofAmylyxPharmaceuticals’treatmentforALSliesanuncom

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Maui's cultural, historic landmarks damaged in the devastating wildfires

          4:12AsatelliteimageshowsanoverviewofBanyancourtinLahaina,Maui,Aug.9,2023.MaxarTechnologiesviaAFP/Get